000 01733 a2200469 4500
005 20250517055856.0
264 0 _c20160801
008 201608s 0 0 eng d
022 _a1815-7920
024 7 _a10.5588/ijtld.14.0935
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aManika, K
245 0 0 _aRifampicin-moxifloxacin interaction in tuberculosis treatment: a real-life study.
_h[electronic resource]
260 _bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
_cNov 2015
300 _a1383-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntitubercular Agents
_xpharmacokinetics
650 0 4 _aDrug Interactions
650 0 4 _aDrug Therapy, Combination
650 0 4 _aExtensively Drug-Resistant Tuberculosis
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aFluoroquinolones
_xpharmacokinetics
650 0 4 _aGreece
650 0 4 _aHumans
650 0 4 _aIsoniazid
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMoxifloxacin
650 0 4 _aOutpatients
650 0 4 _aRifampin
_xtherapeutic use
650 0 4 _aTuberculosis, Pulmonary
_xdrug therapy
700 1 _aChatzika, K
700 1 _aPapaioannou, M
700 1 _aKontou, P
700 1 _aBoutou, A
700 1 _aZarogoulidis, K
700 1 _aKioumis, I
773 0 _tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
_gvol. 19
_gno. 11
_gp. 1383-7
856 4 0 _uhttps://doi.org/10.5588/ijtld.14.0935
_zAvailable from publisher's website
999 _c25354714
_d25354714